The BATTLE Trial: Personalizing Therapy for Lung Cancer

BACKGROUND: Lung cancer is the leading cancer cause of mortality worldwide; large-scale trials have failed to improve clinical outcomes of patients with chemorefractory non-small-cell lung cancer (NSCLC). METHODS: Following an initial equal randomization period, BATTLE adaptively randomized patients...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kim, Edward S., Herbst, Roy S., Wistuba, Ignacio I., Lee, J. Jack, Blumenschein, George R., Tsao, Anne, Stewart, David J., Hicks, Marshall E., Erasmus, Jeremy, Gupta, Sanjay, Alden, Christine M., Liu, Suyu, Tang, Ximing, Khuri, Fadlo R., Tran, Hai T., Johnson, Bruce E., Heymach, John V., Mao, Li, Fossella, Frank, Kies, Merrill, Papadimitrakopoulou, Vassiliki, Davis, Suzanne E., Lippman, Scott M., Hong, Waun K.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4211116/
https://ncbi.nlm.nih.gov/pubmed/22586319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8274.CD-10-0010
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky